Characterizing regional drug delivery within the nasal airways

References

• Tiwari G, Tiwari R, Sriwastawa B, et al. Drug delivery systems: An updated review. Int J Pharma Investig. 2012;2(1):2–11. doi: 10.4103/2230-973X.96920
   PubMedGoogle Scholar
• Tepper DE. Nasal sprays for the treatment of migraine. Headache. 2013;53:577–578. doi: 10.1111/head.12045
   PubMed Web of Science ®Google Scholar
• Taylor D, Radbruch L, Revnic J, et al. A report on the long-term use of fentanyl pectin nasal spray in patients with recurrent breakthrough pain. J Pain Symptom Manag. 2014;47(6):1001–1007. doi: 10.1016/j.jpainsymman.2013.07.012
   PubMed Web of Science ®Google Scholar
• Miyake MM, Bleier BS. The blood-brain barrier and nasal drug delivery to the central nervous system. Am J Rhinol Allergy. 2015;29(2):124–127. doi: 10.2500/ajra.2015.29.4149
   PubMed Web of Science ®Google Scholar
• Quintana DS, Westlye LT, Rustan ØG, et al. Low-dose oxytocin delivered intranasally with breath powered device affects social-cognitive behavior: a randomized four-way crossover trial with nasal cavity dimension assessment. Transl Psychiatry. 2015;5:e602. doi: 10.1038/tp.2015.93
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration. Nasal spray and inhalation solution, suspension, and spray drug products - chemistry. Manufacturing, And Controls Documentation. 2002.
   Google Scholar
• Veronesi MC, Alhamami M, Miedema SB, et al. Imaging of intranasal drug delivery to the brain. Am J Nucl Med Mol Imaging. 2020;10:1–31.
   PubMed Web of Science ®Google Scholar
• Balyasnikova IV, Prasol MS, Ferguson SD, et al. Intranasal delivery of mesenchymal stem cells significantly extends survival of irradiated mice with experimental brain tumors. Mol Ther. 2014;22(1):140–148. doi: 10.1038/mt.2013.199
   PubMed Web of Science ®Google Scholar
• Leach CL, Kuehl PJ, Chand R, et al. Nasal deposition of HFA-Beclomethasone, aqueous fluticasone propionate and aqueous mometasone furoate in allergic rhinitis patients. J Aerosol Med Pulm Drug Deliv. 2015;28(5):334–340. doi: 10.1089/jamp.2014.1180
   PubMed Web of Science ®Google Scholar
• Schroeter JD, Tewksbury EW, Wong BA, et al. Experimental measurements and computational predictions of regional particle deposition in a sectional nasal model. J Aerosol Med Pulm Drug Deliv. 2015;28(1):20–29. doi: 10.1089/jamp.2013.1084
   PubMed Web of Science ®Google Scholar
• Keeler JA, Patki A, Woodard CR, et al. A computational study of nasal spray deposition pattern in four Ethnic Groups. J Aerosol Med Pulm Drug Deliv. 2016;29(2):153–166. doi: 10.1089/jamp.2014.1205
   PubMed Web of Science ®Google Scholar
• Cabrera M, Michelet O, Piazzoni E, et al. Development of in vitro nasal cast imaging techniques to predict in vivo nasal deposition. Respiratory drug delivery Europe 2017. River Grove (IL USA): DHI Publishing; 2017. p. 325.
   Google Scholar
• Chen JZ, Kiaee M, Martin AR, et al. In vitro assessment of an idealized nose for nasal spray testing: comparison with regional deposition in realistic nasal replicas. Int J Pharm. 2020;582:119341.
   PubMedGoogle Scholar
• Manniello MD, Hosseini S, Alfaifi A, et al. In vitro evaluation of regional nasal drug delivery using multiple anatomical nasal replicas of adult human subjects and two nasal sprays. Int J Pharm. 2021;593:120103. doi: 10.1016/j.ijpharm.2020.120103
   PubMed Web of Science ®Google Scholar
• Hosseini S, Alfaifi A, Esmaeili AR, et al. Effects of nasal anatomical characteristics and administration parameters on delivery of locally-acting drugs with suspension nasal sprays in adults. J Aerosol Sci. 2023;167:106101. doi: 10.1016/j.jaerosci.2022.106101
   Web of Science ®Google Scholar
• Kimbell JS, Segal RA, Asgharian B, et al. Characterization of deposition from nasal spray devices using a computational fluid dynamics model of the human nasal passages. J Aerosol Med. 2007;20(1):59–74. doi: 10.1089/jam.2006.0531
   PubMedGoogle Scholar
• Inthavong K, Tian ZF, Tu JY, et al. Optimising nasal spray parameters for efficient drug delivery using computational fluid dynamics. Comput Biol Med. 2008;38(6):713–726. doi: 10.1016/j.compbiomed.2008.03.008
   PubMed Web of Science ®Google Scholar
• Rygg A, Hindle M, Longest PW. Linking suspension nasal spray drug deposition patterns to pharmacokinetic profiles: a proof-of-concept study using computational fluid dynamics. J Pharm Sci. 2016;105(6):1995–2004. doi: 10.1016/j.xphs.2016.03.033
   PubMed Web of Science ®Google Scholar
• Davis SS. Nasal vaccines. Adv Drug Deliv Rev. 2001;51(1–3):21–42. doi: 10.1016/S0169-409X(01)00162-4
   PubMed Web of Science ®Google Scholar
• Agrawal M, Saraf S, Saraf S, et al. Nose-to-brain drug delivery: an update on clinical challenges and progress towards approval of anti-Alzheimer drugs. J Control Release. 2018;281:139–177. doi: 10.1016/j.jconrel.2018.05.011
   PubMed Web of Science ®Google Scholar
• Deruyver L, Rigaut C, Lambert P, et al. The importance of pre-formulation studies and of 3D-printed nasal casts in the success of a pharmaceutical product intended for nose-to-brain delivery. Adv Drug Deliv Rev. 2021;175:113826. doi: 10.1016/j.addr.2021.113826
   PubMed Web of Science ®Google Scholar
• Le Guellec S, Ehrmann S, Vecellio L. In vitro - in vivo correlation of intranasal drug deposition. Adv Drug Deliv Rev. 2021;170:340–352. doi: 10.1016/j.addr.2020.09.002
   PubMed Web of Science ®Google Scholar
• Tafaghodi M, Abolghasem Sajadi Tabassi S, Jaafari M-R, et al. Evaluation of the clearance characteristics of various microspheres in the human nose by gamma-scintigraphy. Int J Pharm. 2004;280(1–2):125–135. doi: 10.1016/j.ijpharm.2004.05.009
   PubMed Web of Science ®Google Scholar
• Soane RJ, Frier M, Perkins AC, et al. Evaluation of the clearance characteristics of bioadhesive systems in humans. Int J Pharm. 1999;178(1):55–65. doi: 10.1016/S0378-5173(98)00367-6
   PubMed Web of Science ®Google Scholar
• Yuki Y, Nochi T, Harada N, et al. In vivo molecular imaging analysis of a nasal vaccine that induces protective immunity against botulism in nonhuman primates. J Immunol. 2010;185:5436–5443. doi: 10.4049/jimmunol.1001789
   PubMed Web of Science ®Google Scholar
• Van de Bittner GC, Van de Bittner KC, Wey H-Y, et al. Positron emission tomography assessment of the intranasal delivery route for orexin a. ACS Chem Neurosci. 2018;9(2):358–368. doi: 10.1021/acschemneuro.7b00357
   PubMed Web of Science ®Google Scholar
• Vidgren P, Vidgren M, Paronen P, et al. Nasal distribution of radioactive drug administered using two dosage forms. Eur J Drug Metab Pharmacokinet. 1991;Spec(3):426–432.
   Google Scholar
• Suman JD, Laube BL, Dalby R. Comparison of nasal deposition and clearance of aerosol generated by nebulizer and an aqueous spray pump. Pharm Res. 1999;16(10):1648–1652. doi: 10.1023/A:1011933410898
   PubMed Web of Science ®Google Scholar
• Seow HC, Liao Q, Lau ATY, et al. Dual targeting powder formulation of antiviral agent for customizable nasal and lung deposition profile through single intranasal administration. Int J Pharm. 2022;619:121704. doi: 10.1016/j.ijpharm.2022.121704
   PubMedGoogle Scholar
• Al-Ghananeem AM, Sandefer EP, Doll WJ, et al. Gamma scintigraphy for testing bioequivalence: a case study on two cromolyn sodium nasal spray preparations. Int J Pharm. 2008;357(1–2):70–76. doi: 10.1016/j.ijpharm.2008.01.040
   PubMedGoogle Scholar
• Djupesland PG, Skretting A. Nasal deposition and clearance in man: comparison of a bidirectional powder device and a traditional liquid spray pump. J Aerosol Med Pulm Drug Deliv. 2012;25(5):280–289. doi: 10.1089/jamp.2011.0924
   PubMed Web of Science ®Google Scholar
• Hoekman J, Brunelle A, Hite M, et al. SPECT Imaging of Direct Nose-to-Brain Transfer of MAG-3 in Man. Proceedings of the Am Assoc Pharm Scientist Annual Meeting; 10–14 November 2013; San Antonio, TX, USA.
   Google Scholar
• Food and drug administration. Bioavailability and Bioequivalence Studies for Nasal Aerosols and Nasal Sprays for Local Action. 2003.
   Google Scholar
• Newman SP, Pitcairn GR, Dalby RN. Drug delivery to the nasal cavity: in vitro and in vivo assessment. Crit Rev Ther Drug Carrier Syst. 2004;21(1):46–66. doi: 10.1615/CritRevTherDrugCarrierSyst.v21.i1.20
   Web of Science ®Google Scholar
• Lelong N, Junqua-Moullet A, Diot P, et al. Comparison of laser diffraction measurements by Mastersizer X and Spraytec to characterize droplet size distribution of medical liquid aerosols. J Aerosol Med Pulm Drug Deliv. 2014;27(2):94–102. doi: 10.1089/jamp.2012.1030
   PubMed Web of Science ®Google Scholar
• Dayal P, Shaik MS, Singh M. Evaluation of different parameters that affect droplet-size distribution from nasal sprays using the malvern Spraytec®. J Pharm Sci. 2004;93(7):1725–1742. doi: 10.1002/jps.20090
   PubMed Web of Science ®Google Scholar
• Pozzoli M, Rogueda P, Zhu B, et al. Dry powder nasal drug delivery: challenges, opportunities and a study of the commercial teijin puvlizer rhinocort device and formulation. Drug Dev Ind Pharm. 2016;42(10):1660–1668. doi: 10.3109/03639045.2016.1160110
   PubMed Web of Science ®Google Scholar
• Suman JD, Laube BL, Dalby R. Validity of in vitro tests on aqueous spray pumps as surrogates for nasal deposition, absorption, and biologic response. J Aerosol Med. 2006;19(4):510–521. doi: 10.1089/jam.2006.19.510
   PubMedGoogle Scholar
• Kundoor V, Dalby RN. Assessment of nasal spray deposition pattern in a silicone human nose model using a color-based method. Pharm Res. 2010;27:30–36. doi: 10.1007/s11095-009-0002-4
   PubMed Web of Science ®Google Scholar
• Guo C, Stine KJ, Kauffman JF, et al. Assessment of the influence factors on in vitro testing of nasal sprays using Box-Behnken experimental design. Eur J Pharm Sci. 2008;35(5):417–426. doi: 10.1016/j.ejps.2008.09.001
   PubMed Web of Science ®Google Scholar
• Cheng YS, Holmes TD, Gao J, et al. Characterization of nasal spray pumps and deposition pattern in a replica of the human nasal airway. J Aerosol Med. 2001;14(2):267–280. doi: 10.1089/08942680152484199
   PubMedGoogle Scholar
• Shah SA, Dickens CJ, Ward DJ, et al. Design of experiments to optimize an in vitro cast to predict human nasal drug deposition. J Aerosol Med Pulm Drug Deliv. 2014;27(1):21–29. doi: 10.1089/jamp.2012.1011
   PubMed Web of Science ®Google Scholar
• Foo MY, Cheng Y-S, Su W-C, et al. The influence of spray properties on intranasal deposition. J Aerosol Med. 2007;20(4):495–508. doi: 10.1089/jam.2007.0638
   PubMedGoogle Scholar
• Warnken ZN, Smyth HDC, Davis DA, et al. Personalized medicine in nasal delivery: the use of patient-specific administration parameters to improve nasal drug targeting using 3D-Printed nasal replica casts. Mol Pharm. 2018;15(4):1392–1402. doi: 10.1021/acs.molpharmaceut.7b00702
   PubMed Web of Science ®Google Scholar
• Xi J, Yuan JE, Zhang Y, et al. Visualization and quantification of nasal and olfactory deposition in a sectional adult nasal airway cast. Pharm Res. 2016;33:1527–1541. doi: 10.1007/s11095-016-1896-2
   PubMed Web of Science ®Google Scholar
• Hughes R, Watterson J, Dickens C, et al. Development of a nasal cast model to test medicinal nasal devices. Proc Inst Mech Eng H. 2008;222:1013–1022. doi: 10.1243/09544119JEIM423
   PubMed Web of Science ®Google Scholar
• Guo Y, Laube B, Dalby R. The effect of formulation variables and breathing patterns on the site of nasal deposition in an anatomically correct model. Pharm Res. 2005;22:1871–1878. doi: 10.1007/s11095-005-7391-9
   PubMed Web of Science ®Google Scholar
• Kleinstreuer C, Zhang Z, Donohue JF. Targeted drug-aerosol delivery in the human respiratory system. Annu Rev Biomed Eng. 2008;10(1):195–220. doi: 10.1146/annurev.bioeng.10.061807.160544
   PubMedGoogle Scholar
• Pu Y, Goodey AP, Fang X, et al. A comparison of the deposition patterns of different nasal spray formulations using a nasal cast. Aerosol Sci Technol. 2014;48:930–938. doi: 10.1080/02786826.2014.931566
   Web of Science ®Google Scholar
• Alfaifi A, Hosseini S, Esmaeili AR, et al. Anatomically realistic nasal replicas capturing the range of nasal spray drug delivery in adults. Int J Pharm. 2022;622:121858.
   PubMed Web of Science ®Google Scholar
• Kiaee M, Wachtel H, Noga ML, et al. An idealized geometry that mimics average nasal spray deposition in adults: a computational study. Comput Biol Med. 2019;107:206–217. doi: 10.1016/j.compbiomed.2019.02.013
   PubMed Web of Science ®Google Scholar
• Kiaee M, Wachtel H, Noga ML, et al. Regional deposition of nasal sprays in adults: a wide ranging computational study. Int J Numer Method Biomed Eng. 2018;34(5):e2968. doi: 10.1002/cnm.2968
   PubMed Web of Science ®Google Scholar
• Chen J, Martin AR, Finlay WH. Recent in vitro and in silico advances in the understanding of intranasal drug delivery. Curr Pharm Des. 2021;27(12):1482–1497. doi: 10.2174/1381612826666201112143230
   PubMed Web of Science ®Google Scholar
• Williams G, Suman JD. In vitro anatomical models for nasal drug delivery. Pharmaceutics. 2022;14:1353. doi: 10.3390/pharmaceutics14071353
   PubMed Web of Science ®Google Scholar
• Liu Y, Johnson MR, Matida EA, et al. Creation of a standardized geometry of the human nasal cavity. J Appl Physiol (1985). 2009;106(3):784–795. doi: 10.1152/japplphysiol.90376.2008
   PubMed Web of Science ®Google Scholar
• Liu Y, Matida EA, Johnson MR. Experimental measurements and computational modeling of aerosol deposition in the Carleton-Civic standardized human nasal cavity. J Aerosol Sci. 2010;41:569–586. doi: 10.1016/j.jaerosci.2010.02.014
   Web of Science ®Google Scholar
• Darunkola MK. Simulation of spray deposition in adults nasal airway [internet]. ERA; 2018 [cited 2024 Feb 5]. Available from: https://era.library.ualberta.ca/items/54999f4d-b89f-4c21-94bf-db6afd1a0f35
   Google Scholar
• Chen JZ, Finlay WH, Martin A. In vitro regional deposition of nasal sprays in an idealized nasal inlet: comparison with in vivo Gamma Scintigraphy. Pharm Res. 2022;39:3021–3028. doi: 10.1007/s11095-022-03388-7
   PubMed Web of Science ®Google Scholar
• Kippax P, Suman J. Characterizing the performance of nasal dry powder devices. Presentation at RDD 2011.
   Google Scholar
• Vehring R. Pharmaceutical particle engineering via spray drying. Pharm Res. 2008;25:999–1022. doi: 10.1007/s11095-007-9475-1
   PubMed Web of Science ®Google Scholar
• Murphy B, Aisenstat M, Ordoubadi M, et al. Intranasal powder administration of a spray dried tuberculosis vaccine candidate characterized using the alberta idealized nasal inlet. Respiratory drug delivery 2022. Orlando (FL); 2022. p. 441–446. https://www.rddonline.com/rdd/article.php?ArticleID=2911&id=21 for more information.
   Google Scholar
• Potts JC, Penn LC, Ahad J, et al. Investigations into the relationship between spray dried powder particle size and deposition in nose and Lung Analogues when actuated from a nasal device. Nice (France); 2023. p. 431–436. https://rddonline.org/rdd/article.php?ArticleID=2991&id=22 for more information.
   Google Scholar
• Henriques P, Bicker J, Carona A, et al. Amorphous nasal powder advanced performance: in vitro/ex vivo studies and correlation with in vivo pharmacokinetics. J Pharm Investig. 2023;53(5):723–742. doi: 10.1007/s40005-023-00630-1
   Google Scholar
• Silva L, Farias G, Hauchard N et al. The relevance of non-standardised in vitro nasal cast models in product development. Edinburgh (UK). 2022. https://ddl-conference.com/ddl2022/conference-papers/the-relevance-of-non-standardised-in-vitro-nasal-cast-models-in-product-development/ for more information.
   Google Scholar
• Laube BL, Sharpless G, Vikani AR, et al. Intranasal deposition of accuspray™ aerosol in anatomically correct models of 2-, 5-, and 12-year-old children. J Aerosol Med Pulm Drug Deliv. 2015;28(5):320–333. doi: 10.1089/jamp.2014.1174
   PubMed Web of Science ®Google Scholar
• Sawant N, Donovan MD. In vitro assessment of spray deposition patterns in a pediatric (12 year-old) nasal cavity model. Pharm Res. 2018;35:108. doi: 10.1007/s11095-018-2385-6
   PubMed Web of Science ®Google Scholar
• Doughty DV, Vibbert C, Kewalramani A, et al. Automated actuation of nasal spray products: determination and comparison of adult and pediatric settings. Drug Dev Ind Pharm. 2011;37(3):359–366. doi: 10.3109/03639045.2010.520321
   PubMed Web of Science ®Google Scholar
• Li C, Zhao K, Shusterman D, et al.et al. Clinical CFD applications 1. In: Inthavong K, Singh N Wong E, editors. Clinical and biomedical engineering in the human nose: a computational fluid dynamics approach [internet]. Singapore: Springer; 2021 [cited 2023 Oct 30] p. 193–223. doi: 10.1007/978-981-15-6716-2_9
   Google Scholar
• Feng Y, Hayati H, Bates AJ, et al.et al. Clinical CFD applications 2. In: Inthavong K, Singh N Wong E, editors. Clinical and biomedical engineering in the human nose: a computational fluid dynamics approach [internet]. Singapore: Springer; 2021. [cited 2023 Oct 30]. p. 225–253. doi: 10.1007/978-981-15-6716-2_10
   Google Scholar
• Tu J, Inthavong K, Ahmadi G. Computational fluid and particle dynamics (CFPD): an introduction. Comp Flu Part Dyna Hum Resp Sys. 2012 Sep 18:1–18. doi: 10.1007/978-94-007-4488-2_1. PMCID: PMC7123128
   Google Scholar
• Djupesland PG. Nasal drug delivery devices: characteristics and performance in a clinical perspective—a review. Drug Deliv Transl Res. 2013;3(1):42–62.
   PubMed Web of Science ®Google Scholar
• Cole P. Nasal and oral airflow resistors. Site, function, and assessment. Arch Otolaryngol Head Neck Surg. 1992;118(8):790–793. doi: 10.1001/archotol.1992.01880080012004
   PubMedGoogle Scholar
• Fodil R, Brugel-Ribere L, Croce C, et al. Inspiratory flow in the nose: a model coupling flow and vasoerectile tissue distensibility. J Appl Physiol 1985. 2005;98(1):288–295. doi: 10.1152/japplphysiol.00625.2004
   Google Scholar
• Shi H. Numerical simulation of airflow, particle deposition and drug delivery in a representative human nasal airway model [internet]. [Raleigh (NC)]: North Carolina State University; 2007 [cited 2023 Oct 30]. Available from: https://repository.lib.ncsu.edu/handle/1840.16/4416
   Google Scholar
• Shi H, Kleinstreuer C, Zhang Z. Modeling of inertial particle transport and deposition in human nasal cavities with wall roughness. J Aerosol Sci. 2007;38:398–419. doi: 10.1016/j.jaerosci.2007.02.002
   Web of Science ®Google Scholar
• Subramaniam RP, Richardson RB, Morgan KT, et al. Computational fluid dynamics simulations of inspiratory airflow in the human nose and nasopharynx. Inhal Toxicol. 1998;10:91–120. doi: 10.1080/089583798197772
   Web of Science ®Google Scholar
• Schroeter JD, Kimbell JS, Asgharian B. Analysis of particle deposition in the turbinate and olfactory regions using a human nasal computational fluid dynamics model. J Aerosol Med. 2006;19(3):301–313. doi: 10.1089/jam.2006.19.301
   PubMedGoogle Scholar
• Inthavong K, Tian ZF, Li HF, et al. A numerical study of spray particle deposition in a human nasal cavity. Aerosol Sci Technol. 2006;40:1034–1045. doi: 10.1080/02786820600924978
   Web of Science ®Google Scholar
• Inthavong K, Ge Q, Se CMK, et al. Simulation of sprayed particle deposition in a human nasal cavity including a nasal spray device. J Aerosol Sci. 2011;42:100–113. doi: 10.1016/j.jaerosci.2010.11.008
   Web of Science ®Google Scholar
• Inthavong K, Fung MC, Yang W, et al. Measurements of droplet size distribution and analysis of nasal spray atomization from different actuation pressure. J Aerosol Med Pulm Drug Deliv. 2015;28(1):59–67. doi: 10.1089/jamp.2013.1093
   PubMed Web of Science ®Google Scholar
• Kolanjiyil AV, Hosseini S, Alfaifi A, et al. Importance of cloud motion and two-way momentum coupling in the transport of pharmaceutical nasal sprays. J Aerosol Sci. 2021;156:105770. doi: 10.1016/j.jaerosci.2021.105770
   Web of Science ®Google Scholar
• Kolanjiyil AV, Alfaifi A, Aladwani G, et al. Importance of spray–wall interaction and post-deposition liquid motion in the transport and delivery of pharmaceutical nasal sprays. Pharmaceutics. 2022;14(5):956. doi: 10.3390/pharmaceutics14050956
   PubMed Web of Science ®Google Scholar
• Calmet H, Oks D, Santiago A, et al. Validation and sensitivity analysis for a nasal spray deposition computational model. Int J Pharm. 2022;626:122118. doi: 10.1016/j.ijpharm.2022.122118
   PubMedGoogle Scholar
• Kolanjiyil AV, Walenga R, Babiskin A, et al. Establishing quantitative relationships between changes in nasal spray in vitro metrics and drug delivery to the posterior nasal region. Int J Pharm. 2023;635:122718. doi: 10.1016/j.ijpharm.2023.122718
   PubMedGoogle Scholar
• Frank DO, Kimbell JS, Pawar S, et al. Effects of anatomy and particle size on nasal sprays and nebulizers. Otolaryngol--Head Neck Surg. 2012;146(2):313–319. doi: 10.1177/0194599811427519
   PubMed Web of Science ®Google Scholar
• Rygg A, Longest PW. Absorption and clearance of pharmaceutical aerosols in the human nose: development of a CFD model. J Aerosol Med Pulm Drug Deliv. 2016;29(5):416–431. doi: 10.1089/jamp.2015.1252
   PubMed Web of Science ®Google Scholar
• Gänger S, Schindowski K. Tailoring formulations for intranasal nose-to-brain delivery: a review on architecture, physico-chemical characteristics and mucociliary clearance of the nasal olfactory mucosa. Pharmaceutics. 2018;10:116. doi: 10.3390/pharmaceutics10030116
   PubMed Web of Science ®Google Scholar
• Sahin-Yilmaz A, Naclerio RM. Anatomy and physiology of the upper airway. Proc Am Thorac Soc. 2011;8(1):31–39. doi: 10.1513/pats.201007-050RN
   PubMedGoogle Scholar
• Illum L. Nasal drug delivery—possibilities, problems and solutions. J Control Release. 2003;87(1–3):187–198. doi: 10.1016/S0168-3659(02)00363-2
   PubMed Web of Science ®Google Scholar
• Johnson NJ, Hanson LR, Frey WH. Trigeminal pathways deliver a low molecular weight drug from the nose to the brain and orofacial structures. Mol Pharm. 2010;7(3):884–893. doi: 10.1021/mp100029t
   PubMed Web of Science ®Google Scholar
• Dhuria SV, Hanson LR, Frey WH. Intranasal delivery to the central nervous system: mechanisms and experimental considerations. J Pharm Sci. 2010;99(4):1654–1673. doi: 10.1002/jps.21924
   PubMed Web of Science ®Google Scholar
• Bahadur S, Pathak K. Physicochemical and physiological considerations for efficient nose-to-brain targeting. Expert Opin Drug Deliv. 2012;9(1):19–31. doi: 10.1517/17425247.2012.636801
   PubMed Web of Science ®Google Scholar
• Shrewsbury SB. The upper nasal space: option for systemic drug delivery, mucosal vaccines and “nose-to-brain”. Pharmaceutics. 2023;15(6):1720.
   PubMed Web of Science ®Google Scholar
• Hazeri M, Faramarzi M, Sadrizadeh S, et al. Regional deposition of the allergens and micro-aerosols in the healthy human nasal airways. J Aerosol Sci. 2021;152:105700. doi: 10.1016/j.jaerosci.2020.105700
   PubMed Web of Science ®Google Scholar
• Pina Costa C, Nižić Nodilo L, Silva R, et al. In situ hydrogel containing diazepam-loaded nanostructured lipid carriers (DZP-NLC) for nose-to-brain delivery: development, characterization and deposition studies in a 3D-printed human nasal cavity model. Int J Pharmaceut. 2023;644:123345. doi: 10.1016/j.ijpharm.2023.123345
   PubMed Web of Science ®Google Scholar
• Cunha S, Swedrowska M, Bellahnid Y, et al. Thermosensitive in situ hydrogels of rivastigmine-loaded lipid-based nanosystems for nose-to-brain delivery: characterisation, biocompatibility, and drug deposition studies. Int J Pharm. 2022;620:121720. doi: 10.1016/j.ijpharm.2022.121720
   PubMedGoogle Scholar
• Trows S, Wuchner K, Spycher R, et al. Analytical challenges and regulatory requirements for nasal drug products in Europe and the U.S. Pharmaceutics. 2014;6:195–219. doi: 10.3390/pharmaceutics6020195
   PubMedGoogle Scholar
• Yarragudi SB, Richter R, Lee H, et al. Formulation of olfactory-targeted microparticles with tamarind seed polysaccharide to improve nose-to-brain transport of drugs. Carbohydr Polym. 2017;163:216–226. doi: 10.1016/j.carbpol.2017.01.044
   PubMed Web of Science ®Google Scholar
• Liu Y, Wu D. Bi-directional nasal drug delivery systems: a scoping review of nasal particle deposition patterns and clinical application. Laryngoscope Investig Oto. 2023;8(6):1484–1499. doi: 10.1002/lio2.1190
   PubMed Web of Science ®Google Scholar
• Xi J, Si XA, Gaide R, et al. Electrophoretic particle guidance significantly enhances olfactory drug delivery: a feasibility study. PLoS One. 2014;9(1):e86593. doi: 10.1371/journal.pone.0086593
   PubMed Web of Science ®Google Scholar
• Xi J, Yuan JE, Si XA, et al. Numerical optimization of targeted delivery of charged nanoparticles to the ostiomeatal complex for treatment of rhinosinusitis. Int J Nanomedicine. 2015;10:4847–4861. doi: 10.2147/IJN.S87382
   PubMed Web of Science ®Google Scholar
• Xi J, Zhang Z, Si XA. Improving intranasal delivery of neurological nanomedicine to the olfactory region using magnetophoretic guidance of microsphere carriers. Int J Nanomedicine. 2015;10:1211–1222. doi: 10.2147/IJN.S77520
   PubMed Web of Science ®Google Scholar
• Xi J, Yuan JE, Alshaiba M, et al. Design and testing of electric-guided delivery of charged particles to the olfactory region: experimental and numerical studies. Curr Drug Deliv. 2016;13(2):265–274. doi: 10.2174/1567201812666150909093050
   PubMed Web of Science ®Google Scholar
• Basu S, Holbrook LT, Kudlaty K, et al. Numerical evaluation of spray position for improved nasal drug delivery. Sci Rep. 2020;10:10568. doi: 10.1038/s41598-020-66716-0
   PubMed Web of Science ®Google Scholar
• Vahaji S, Shang Y, Zhang Y, et al. Optimising aerosol delivery for maxillary sinus deposition in a post-FESS sinonasal cavities. Aerosol Air Qual Res. 2021;21(12):210098. doi: 10.4209/aaqr.210098
   Web of Science ®Google Scholar
• Li C, Wang J, Wang Y, et al. Recent progress in drug delivery. Acta Pharm Sin B. 2019;9(6):1145–1162. doi: 10.1016/j.apsb.2019.08.003
   PubMed Web of Science ®Google Scholar
• Abdollahzadeh Jamalabadi MY, Xi J. Olfactory drug aerosol delivery with acoustic radiation. Biomedicines. 2022;10:1347. doi: 10.3390/biomedicines10061347
   PubMed Web of Science ®Google Scholar
• Papakyriakopoulou P, Rekkas DM, Colombo G, et al. Development and in vitro-ex vivo evaluation of novel polymeric nasal donepezil films for potential use in Alzheimer’s disease using experimental design. Pharmaceutics. 2022;14:1742. doi: 10.3390/pharmaceutics14081742
   PubMed Web of Science ®Google Scholar
• Kaikousidis C, Papakyriakopoulou P, Dokoumetzidis A, et al. Donepezil brain and blood pharmacokinetic modeling after nasal film and oral solution administration in mice. Pharmaceutics. 2023;15:1409. doi: 10.3390/pharmaceutics15051409
   PubMed Web of Science ®Google Scholar
• Menegatou I-M, Papakyriakopoulou P, Rekkas DM, et al. Design of a personalized nasal device (matrix-piston nasal device, MPD) for drug delivery: a 3D-Printing application. AAPS Pharm Sci Tech. 2022;23:205. doi: 10.1208/s12249-022-02351-4
   PubMed Web of Science ®Google Scholar
• Lavelle EC, Ward RW. Mucosal vaccines — fortifying the frontiers. Nat Rev Immunol. 2022;22:236–250. doi: 10.1038/s41577-021-00583-2
   PubMed Web of Science ®Google Scholar
• Fukuyama Y, Okada K, Yamaguchi M, et al. Nasal administration of cholera toxin as a mucosal adjuvant damages the olfactory system in mice. PLoS One. 2015;10(9):e0139368. doi: 10.1371/journal.pone.0139368
   PubMed Web of Science ®Google Scholar
• Lobaina Mato Y. Nasal route for vaccine and drug delivery: features and current opportunities. Int J Pharmaceut. 2019;572:118813. doi: 10.1016/j.ijpharm.2019.118813
   PubMed Web of Science ®Google Scholar
• Suman JD. Current understanding of nasal morphology and physiology as a drug delivery target. Drug Deliv Transl Res. 2013;3(1):4–15. doi: 10.1007/s13346-012-0121-z
   PubMed Web of Science ®Google Scholar
• Yu Y-S, AboulFotouh K, Xu H, et al. Feasibility of intranasal delivery of thin-film freeze-dried, mucoadhesive vaccine powders. Int J Pharmaceut. 2023;640:122990. doi: 10.1016/j.ijpharm.2023.122990
   PubMed Web of Science ®Google Scholar
• AboulFotouh K, Xu H, Moon C, et al. Development of (inhalable) dry powder formulations of AS01B-Containing vaccines using thin-film freeze-drying. Int J Pharmaceut. 2022;622:121825. doi: 10.1016/j.ijpharm.2022.121825
   PubMed Web of Science ®Google Scholar
• Wilkins JV, Golshahi L, Rahman N, et al. Evaluation of intranasal vaccine delivery using anatomical replicas of infant nasal airways. Pharm Res. 2021;38:141–153. doi: 10.1007/s11095-020-02976-9
   PubMed Web of Science ®Google Scholar
• Li L, Wilkins JV, Esmaeili AR, et al. In vitro comparison of local nasal vaccine delivery and correlation with device spray performance. Pharm Res. 2023;40:537–550. doi: 10.1007/s11095-022-03452-2
   PubMed Web of Science ®Google Scholar
• Murphy BM, Chen JZ, Rolo M, et al. Intranasal delivery of a synthetic entamoeba histolytica vaccine containing adjuvant (LecA + GLA-3 M-052 liposomes): in vitro characterization. Int J Pharm. 2022;626:122141. doi: 10.1016/j.ijpharm.2022.122141
   PubMedGoogle Scholar
• Tavernini S, Church TK, Lewis DA, et al. Deposition of micrometer-sized aerosol particles in neonatal nasal airway replicas. Aerosol Sci Technol. 2018;52:407–419. doi: 10.1080/02786826.2017.1413489
   Web of Science ®Google Scholar
• Tavernini S, Church TK, Lewis DA, et al. Scaling an idealized infant nasal airway geometry to mimic inertial filtration of neonatal nasal airways. J Aerosol Sci. 2018;118:14–21. doi: 10.1016/j.jaerosci.2017.12.004
   Web of Science ®Google Scholar
• Topol EJ, Iwasaki A. Operation nasal vaccine—lightning speed to counter COVID-19. Sci Immunol [Internet]. 2022 [cited 2023 Oct 30]. 7(74). Available from: https://www.science.org/doi/10.1126/sciimmunol.add9947
   PubMed Web of Science ®Google Scholar
• Waltz E. China and India approve nasal COVID vaccines — are they a game changer? Nature. 2022;609:450–450. doi: 10.1038/d41586-022-02851-0
   PubMed Web of Science ®Google Scholar
• Sonvico F, Colombo G, Quarta E, et al. Nasal delivery as a strategy for the prevention and treatment of COVID-19. Expert Opin Drug Delivery. 2023;20:1115–1130. doi: 10.1080/17425247.2023.2263363
   PubMed Web of Science ®Google Scholar